Brief: Theravance Biopharma Gets Notice From Pfizer Terminating License Agreement
09/06/2023 22:17
June 9 (Reuters) - Pfizer Inc PFE.N :
* THERAVANCE BIOPHARMA INC-GOT NOTICE FROM PFIZER
TERMINATING
LICENSE AGREEMENT FOR PRECLINICAL PAN-JAK INHIBITOR PROGRAM
EFFECTIVE AS OF OCT 7
Further company coverage: PFE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy